Skip to content

SAVI SCOUT Clinical Evaluation Study

A Prospective, Single-Arm, Multi-Site, Clinical Evaluation of the SAVI SCOUT® Surgical Guidance System for the Location of Non-Palpable Breast Lesions During Excision

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02370082
Enrollment
150
Registered
2015-02-24
Start date
2015-02-28
Completion date
2015-08-31
Last updated
2015-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm

Keywords

lumpectomy, breast conserving surgery

Brief summary

The purpose of this study is to evaluate the performance of the SAVI SCOUT® Surgical Guidance System (SAVI SCOUT). The SAVI SCOUT is a medical device, used to provide real-time guidance during localized excisional biopsy or lumpectomy procedures, by helping the surgeon locate and remove the desired tissue (i.e., the lesion and surrounding normal tissue). The SAVI SCOUT has been 510K cleared. The SAVI SCOUT is intended to assist surgeons in the location and retrieval of a non-palpable abnormality as localized by radiographic or ultrasound methods. In this study, the ability of the SAVI SCOUT to guide surgeons to find a lesion will be evaluated instead of the standard technique of wire localization.

Detailed description

Using radiography or ultrasound guidance, the SAVI SCOUT reflector will be placed percutaneously up to 7 days prior to the scheduled excisional procedure. During surgical excision, the SAVI SCOUT system will be used to locate the reflector, which will be removed along with the surrounding breast tissue. Final data analysis will be completed within 1 month after the last patient is treated. Final assessment of the surgical results will be completed by the surgeon during a routine follow-up visit within 1 month following the surgical excision or lumpectomy procedure. Main Objective: to show that the SAVI SCOUT technique can be used to safely and effectively locate a non-palpable breast lesion during a localized excisional biopsy or lumpectomy procedure. Up to 10 sites and 150 patients will be enrolled.

Interventions

DEVICELocalization of breast lesion

localization of breast lesion for removal

Sponsors

University of South Florida
CollaboratorOTHER
Cianna Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* • Patient has a non-palpable breast lesion that requires excision * Lesion depth ≤ 3 cm from the skin surface in the supine position * Patient is scheduled for excision or BCT at a participating institution * Patient is between the ages of 18 and 90 years * Patient is female * Patient is willing and able to comply with all study procedures and be available to follow-up for the duration of the study * For lesions requiring multiple reflectors for localization, they must allow for reflectors to be placed ≥ 1cm from one another relative to the coronal plane Subject

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study: * Patient had a previous ipsilateral breast cancer * Patient has multicentric breast cancer * Patient has Stage IV breast cancer * Patient has been treated with neoadjuvant chemotherapy * Patient is pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Success rate of reflector placementintraoperativeHow often the reflector can be successfully placed

Secondary

MeasureTime frameDescription
Amount of tissue excisedWill be assessed by pathologist during standard pathology assessment which occurs 24-48 hours after surgeryPathologic assessment of how much tissue was removed
Percent of cases with clear margins • Percent of cases requiring a second operationUpon completion of pathologic assessment-which will occur within 24-48 hours after surgeryHow often patients are not required to have repeat procedures

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026